IDI group B Streptococcus assay
Jump to navigation
Jump to search
Introduction
FDA approved for group B streptococcus screening of pregnant women
Indications
Methods
- detects DNA of group B streptococcus using specialized instrument
- sensitivity: > 85%
- turnaround time: 1 hour
Specimen
More general terms
References
- ↑ Action Report, Medical Board of California, 85:7 (April) 2003
- ↑ http://www.fda.gov/bbs/topics/ANSWERS/2002/ANS01172.html
- ↑ http://www.fda.gov/cdrh/mda/docs/k022504.html